支原体清除剂 (MRA), 5 mL

支原体清除剂 (MRA), 5 mL

Packaging size: 5 mL

SKU 093050044
CN¥2,934.75
Inquire
Request a quote
Description

Product Description

支原体清除剂(MRA)是解决细胞培养中支原体污染严重问题的有效方法。MRA是抗生素奎林家族的衍生物,通过抑制支原体DNA旋转酶解旋酶去除支原体感染。MRA在推荐使用浓度0.5 µg/mL情况下,能够有效去除多种支原体,并且具有预防支原体污染复发的作用。

  • 具有很强的抑制支原体活性的能力,一周之内即可从被污染的培养细胞中彻底去除支原体
  • 活性范围广,可以维持7天药效,对多种支原体株系均有作用
  • 作用浓度低,0.5 μg/mL对支原体有清除作用,对细胞毒性极小
  • 防止支原体污染复发,0.1 μg/mL具有预防支原体的作用
  • 使用方便,只需要添加到支原体污染的培养细胞中

Application Notes

支原体清除剂(MRA) 能够消除细胞培养中支原体可能造成的污染。以推荐浓度使用时,MRA的细胞毒性较低。对于细胞特定功能部分,建议在清除支原体后确认所需细胞特性是否被保留。

Usage Statement

Research Use Only (RUO). Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Key Applications

Elimination of mycoplasma contamination from cell cultures

Specifications
SKU 093050044
Application Notes 支原体清除剂(MRA) 能够消除细胞培养中支原体可能造成的污染。以推荐浓度使用时,MRA的细胞毒性较低。对于细胞特定功能部分,建议在清除支原体后确认所需细胞特性是否被保留。
Base Catalog Number 3050044
Concentration 50 µg/mL(Lit.)
Formulation Details Liquid
Pack Size 5 mL
Physical Appearance Clear, light yellow liquid
Presentation Liquid
Sterility Sterile
Storage and Handling Store at Room Temperature (15-30 °C). Protect from light.
Typical Working Concentration The recommended concentration for use is 0.5 µg/mL. Concentration may be raised up to 1 µg/mL only when the recommended concentration is ineffective in removing the mycoplasma. For preventative purposes, MRA can be used at 0.1 µg/mL.
Usage Statement Research Use Only (RUO). Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.